Hepatitis C linked to risk for non-Hodgkin's lymphoma

Ellis, Kirsten H.
April 2008
Hem/Onc Today;4/25/2008, Vol. 9 Issue 7, p20
The article discusses a research on hepatitis C patients twice as likely to develop non-Hodgkin's lymphoma when compared with a matched control group. It references a study by J. J. Spinelli et al, published in a 2008 issue of the "International Journal of Cancer." Hepatitis C is reportedly a risk factor for type II mixed cryoglobulinemia, which may evolve into B-cell non-Hodgkin's lymphoma. The risk being associated with intravenous drug use and prior blood transfusions is indicated.


Related Articles

  • Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. Brandão, Ajacio B. M.; Fuchs, Sandra Costa // BMC Gastroenterology;2002, Vol. 2, p18 

    Background: In Brazil, it is estimated that between 2.5 and 4.9% of the general population present anti-hepatitis C virus (HCV) antibodies, which corresponds to as many as 3.9 to 7.6 million chronic carriers. Chronic liver disease is associated with HCV infection in 20% to 58% of the Brazilian...

  • Approach to the Patient with Chronic Hepatitis C Virus Infection. Herrine, Steven K. // Annals of Internal Medicine;5/21/2002, Vol. 136 Issue 10, p747 

    Chronic hepatitis C virus (HCV) infection is common and often asymptomatic. Antibodies against HCV are a highly sensitive marker of infection. Molecular testing for HCV is used to confirm a positive result on antibody testing and to provide prognostic information for treatment; however,...

  • The diagnosis of hepatitis C in a semi-rural genitourinary medicine clinic. Markos, A. R. // International Journal of STD & AIDS;Dec2002, Vol. 13 Issue 12, p847 

    A retrospective casenote study was conducted to examine the risk factors for patients who were diagnosed as hepatitis C (HCV)-positive (between 1999 and 2001) in a semi-rural genitourinary medicine (GUM) setting in Staffordshire, UK. There was a remarkable escalation in the number of reported...

  • SEROPREVALENCE OF BLOOD-BORNE INFECTIONS AND POPULATION SIZES ESTIMATES IN A POPULATION OF INJECTING DRUG USERS IN CROATIA. Kolarić, Branko; Štajduhar, Dinko; Gajnik, Davorin; Rukavina, Tomislav; Wiessing, Lucas // Central European Journal of Public Health;2010, Vol. 18 Issue 2, p104 

    Similar to some other Central European countries, Croatia has low HIV prevalence among injecting drug users (IDUs) but high hepatitis C (HCV) prevalence. This may indicate different patterns of risk behaviour in this region than in other parts of Europe. The main objectives of this study were to...

  • Seroprevalence of Hepatitis A Virus in Patients with Chronic Hepatitis B or C in Isfahan Province, Iran. Shoaei, Parisa; Zeidabadinejad, Laleh; Ataei, Behrooz; Babak, Anahita; Nokhodian, Zary; Yaran, Majid; Foroughifar, Maryam; Kassaian, Nazila // Journal of Isfahan Medical School;10/1/2012, Vol. 30 Issue 199, p1 

    Background: A number of researchers have suggested that the clinical course of hepatitis A virus (HAV) infection is more severe in patients with chronic liver disease (CLD). However, there is not adequate information about the seroprevalence and risk factors of HAV in the population with chronic...

  • Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey. Day, Carolyn A.; Ross, Joanne; Dietze, Paul; Dolan, Kate // Harm Reduction Journal;2005, Vol. 2, p2 

    Background: Heroin injection is associated with health and social problems including hepatitis C virus (HCV) transmission. Few studies have examined the circumstances surrounding initiation to heroin injecting, especially current users initiating others. The current study aimed to examine the...

  • The HCV Synthesis Project: Scope, methodology, and preliminary results. Stern, Rebecca K.; Hagan, Holly; Lelutiu-Weinberger, Corina; Jarlais, Don Des; Scheinmann, Roberta; Strauss, Shiela; Pouget, Enrique R.; Flom, Peter // BMC Medical Research Methodology;2008, Vol. 8, Special section p1 

    Background: The hepatitis C virus (HCV) is hyper-endemic in injecting drug users. There is also excess HCV among non-injection drug users who smoke, snort, or sniff heroin, cocaine, crack, or methamphetamine. Methods: To summarize the research literature on HCV in drug users and identify gaps in...

  • High risky behaviors among intravenous drug users in Isfahan, Iran: A study for hepatitis C harm reduction programs. Hassannejad, Razieh; Kassaian, Nazila; Ataei, Behrooz; Adibi, Peyman // International Journal of Preventive Medicine;Mar2012 Supplement, Vol. 3, pS73 

    Objectives: Intravenous drug users (IVDUs) who share needles/syringes and practice sexual behaviors, are the most important group in the transmission of blood-borne infection diseases such as hepatitis C virus (HCV). Therefore identification of prevalent highrisky behaviors among IVDUs to detect...

  • Will the real victims please stand up? McGovern, Celeste // Alberta Report / Newsmagazine;07/13/98, Vol. 25 Issue 30, p41 

    Discusses aspects of the Hepatitis C compensation issue in Canada. Efforts to predict the number of Hepatitis C sufferers who will seek government funds in compensation for tainted blood transfusions that resulted in the infection; Complications that arose in the compensation issue following a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics